KDR and small cell lung carcinoma: Taken together, combining blockade of ANG-2, VEGFR, and PD-1 synergistically prolonged OS and PFS of SCLC-bearing mice and was accompanied by better CD8+ T cell infiltration into tumor tissue in lung and liver.